In vitro and in vivo osteogenic activity of largazole

ACS Medicinal Chemistry Letters

Volumn 2, Issue 3, 2011, Pages 248-251

  Lee, Su Ui ^a   Kwak, Han Bok ^b   Pi, Sung Hee ^b   You, Hyung Keun ^b   Byeon, Seong Rim ^c   Ying, Yongcheng ^c   Luesch, Hendrik ^d   Hong, Jiyong ^c   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Wonkwang University   (South Korea)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

bone morphogenetic protein; histone deacetylases; Largazole; osteogenic activity; Runx2

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; HISTONE DEACETYLASE INHIBITOR; LARGAZOLE; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CALVARIA; CHROMATIN STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TISSUE DIFFERENTIATION;

ORYCTOLAGUS CUNICULUS;

EID: 79952655571     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml1002794     Document Type: Article

References (35)

1. Taori, K.; Paul, V. J.; Luesch, H. Structure and Activity of Largazole, a Potent Antiproliferative Agent from the Floridian Marine Cyanobacterium Symploca sp J. Am. Chem. Soc. 2008, 130, 1806-1807 (Pubitemid 351238618)
2. Ying, Y.; Taori, K.; Kim, H.; Hong, J.; Luesch, H. Total Synthesis and Molecular Target of Largazole, a Histone Deacetylase Inhibitor J. Am. Chem. Soc. 2008, 130, 8455-8459 (Pubitemid 351898566)
3. Liu, Y.; Salvador, L. A.; Byeon, S.; Ying, Y.; Kwan, J. C.; Law, B. K.; Hong, J.; Luesch, H. Anticolon Cancer Activity of Largazole, a Marine-Derived Tunable Histone Deacetylase Inhibitor J. Pharmacol. Exp. Ther. 2010, 335, 351-361
4. Bowers, A.; West, N.; Taunton, J.; Schreiber, S. L.; Bradner, J. E.; Williams, R. M. Total Synthesis and Biological Mode of Action of Largazole: A Potent Class I Histone Deacetylase Inhibitor J. Am. Chem. Soc. 2008, 130, 11219-11222
5. Seiser, T.; Kamena, F.; Cramer, N. Synthesis and Biological Activity of Largazole and Derivatives Angew. Chem., Int. Ed. 2008, 47, 6483-6485
6. Nasveschuk, C. G.; Ungermannova, D.; Liu, X.; Phillips, A. J. A Concise Total Synthesis of Largazole, Solution Structure, and Some Preliminary Structure Activity Relationships Org. Lett. 2008, 10, 3595-3598
7. Ghosh, A. K.; Kulkarni, S. Enantioselective Total Synthesis of (+)-Largazole, a Potent Inhibitor of Histone Deacetylase Org. Lett. 2008, 10, 3907-3909
8. Ying, Y.; Liu, Y.; Byeon, S. R.; Kim, H.; Luesch, H.; Hong, J. Synthesis and Activity of Largazole Analogues with Linker and Macrocycle Modification Org. Lett. 2008, 10, 4021-4024
9. Ren, Q.; Dai, L.; Zhang, H.; Tan, W.; Xu, Z.; Ye, T. Total Synthesis of Largazole Synlett 2008, 2379-2383
10. Numajiri, Y.; Takahashi, T.; Takagi, M.; Shin-ya, K.; Doi, T. Total Synthesis of Largazole and Its Biological Evaluation Synlett 2008, 2483-2486
11. Bowers, A. A.; Greshock, T. J.; West, N.; Estiu, G.; Schreiber, S. L.; Wiest, O.; Williams, R. M.; Bradner, J. E. Synthesis and Conformation-Activity Relationships of the Peptide Isosteres of FK228 and Largazole J. Am. Chem. Soc. 2009, 131, 2900-2905
12. Bowers, A. A.; West, N.; Newkirk, T. L.; Troutman-Youngman, A. E.; Schreiber, S. L.; Wiest, O.; Bradner, J. E.; Williams, R. M. Synthesis and Histone Deacetylase Inhibitory Activity of Largazole Analogs: Alteration of the Zinc-Binding Domain and Macrocyclic Scaffold Org. Lett. 2009, 11, 1301-1304
13. Chen, F.; Gao, A.-H.; Li, J.; Nan, F.-J. Synthesis and Biological Evaluation of C7-Demethyl Largazole Analogues ChemMedChem 2009, 4, 1269-1272
14. Wang, B.; Forsyth, C. J. Total Synthesis of Largazole-Devolution of a Novel Synthetic Strategy Synthesis 2009, 2873-2880
15. Souto, J. A.; Vaz, E.; Lepore, I.; Pöppler, A.-C.; Franci, G.; Álvarez, R.; Altucci, L.; de Lera, Á. R. Synthesis and Biological Characterization of the Histone Deacetylase Inhibitor Largazole and C7-Modified Analogues J. Med. Chem. 2010, 53, 4654-4667
16. Zeng, X.; Yin, B.; Hu, Z.; Liao, C.; Liu, J.; Li, S.; Li, Z.; Nicklaus, M. C.; Zhou, G.; Jiang, S. Total Synthesis and Biological Evaluation of Largazole and Derivatives with Promising Selectivity for Cancers Cells Org. Lett. 2010, 12, 1368-1371
17. Xiao, Q.; Wang, L.-P.; Jiao, X.-Z.; Liu, X.-Y.; Wu, Q.; Xie, P. Concise Total Synthesis of Largazole J. Asian Nat. Prod. Res. 2010, 12, 940-949
18. Katagiri, T.; Takahashi, N. Regulatory Mechanisms of Osteoblast and Osteoclast Differentiation Oral Dis. 2002, 8, 147-159 (Pubitemid 34535063)
19. Jensen, E. D.; Nair, A. K.; Westendorf, J. J. Histone Deacetylase Co-Repressor Complex Control of Runx2 and Bone Formation Crit. Rev. Eukaryot. Gene Expr. 2007, 17, 187-196 (Pubitemid 46884134)
20. Schroeder, T. M.; Westendorf, J. J. Histone Deacetylase Inhibitors Promote Osteoblast Maturation J. Bone Miner. Res. 2005, 20, 2254-2263 (Pubitemid 41698788)
21. Cho, H. H.; Park, H. T.; Kim, Y. J.; Bae, Y. C.; Suh, K. T.; Jung, J. S. Induction of Osteogenic Differentiation of Human Mesenchymal Stem Cells by Histone Deacetylase Inhibitors J. Cell Biochem. 2005, 96, 533-542 (Pubitemid 41504651)
22. Guo, C. Y.; Ronen, G. M.; Atkinson, S. A. Long-Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy Epilepsia 2001, 42, 1141-1147 (Pubitemid 32947933)
23. Boluk, A.; Guzelipek, M.; Savli, H.; Temel, I.; Ozişik, H. I.; Kaygusuz, A. The Effect of Valproate on Bone Mineral Density in Adult Epileptic Patients Pharmacol. Res. 2004, 50, 93-97 (Pubitemid 38479673)
24. Cheng, H.; Jiang, W.; Phillips, F. M.; Haydon, R. C.; Peng, Y.; Zhou, L.; Luu, H. H.; An, N.; Breyer, B.; Vanichakarn, P.; Szatkowski, J. P.; Park, J. Y.; He, T. C. Osteogenic Activity of the 14 Types of Human Bone Morphogenetic Proteins (BMPs) J. Bone Joint Surg. Am. 2003, 85A, 1544-1552 (Pubitemid 36951140)
25. Largazole reduced the expressions of HDACs 2, 3, 4, and 5 but not the expression of HDAC 1 (see the Supporting Information for details).
26. Franceschi, R. T.; Xiao, G. Regulation of the Osteoblast-Specific Transcription Factor, Runx2: Responsiveness to Multiple Signal Transduction Pathways J. Cell Biochem. 2003, 88, 446-454 (Pubitemid 36158266)
27. Kim, H. J.; Park, H. D.; Kim, J. H.; Cho, J. Y.; Choi, J. Y.; Kim, J. K.; Kim, H. J.; Shin, H. I.; Ryoo, H. M. Establishment and Characterization of a Stable Cell Line to Evaluate Cellular Runx2 Activity J. Cell Biochem. 2004, 9, 1239-1247
28. Westendorf, J. J. Transcriptional Co-Repressors of Runx2 J. Cell Biochem. 2006, 98, 54-64
29. McKay, W. F.; Peckham, S. M.; Badura, J. M. A Comprehensive Clinical Review of Recombinant Human Bone Morphogenetic Protein-2 (INFUSE Bone Graft) Int. Orthop. 2007, 31, 729-734 (Pubitemid 350160311)
30. White, A. P.; Vaccaro, A. R.; Hall, J. A.; Whang, P. G.; Friel, B. C.; McKee, M. D. Clinical Applications of BMP-7/OP-1 in Fractures, Nonunions and Spinal Fusion Int. Orthop. 2007, 31, 735-741 (Pubitemid 350160312)
31. Nakashima, M.; Reddi, A. H. The Application of Bone Morphogenetic Proteins to Dental Tissue Engineering Nat. Biotechnol. 2003, 21, 1025-1032 (Pubitemid 37064731)
32. Seeherman, H.; Wozney, J. M. Delivery of Bone Morphogenetic Proteins for Orthopedic Tissue Regeneration Cytokine Growth Factor Rev. 2005, 16, 329-345 (Pubitemid 40910322)
33. Yeo, H.; Beck, L. H.; McDonald, J. M.; Zayzafoon, M. Cyclosporin A Elicits Dose-Dependent Biphasic Effects on Osteoblast Differentiation and Bone Formation Bone 2007, 40, 1502-1516 (Pubitemid 46766648)
34. Jeong, J. G.; Kim, Y. S.; Min, Y. K.; Kim, S. H. Low Concentration of 3-Carene Stimulates the Differentiation of Mouse Osteoblastic MC3T3-E1 Subclone 4 Cells Phytother. Res. 2008, 22, 18-22
35. Lee, S. U.; Shin, H. K.; Min, Y. K.; Kim, S. H. Emodin Accelerates Osteoblast Differentiation through Phosphatidylinositol 3-Kinase Activation and Bone Morphogenetic Protein-2 Gene Expression Int. Immunopharmacol. 2008, 8, 741-747